Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Targeting Cholesterol Homeostasis Pathway to Overcome Acquired Cytarabine Resistance in Acute Myeloid Leukemia

Saswati Das, Raveen Stephen Stallon Illangeswaran, Daniel Zechariah Paul Zechariah Paul Jebanesan, Rakhi Thalayatta Vidhyadharan, Vikram Mathews, Shaji Ramachandran Velayudhan, Poonkuzhali Balasubramanian

Blood (2022) 140 (Supplement 1): 11543.

https://doi.org/10.1182/blood-2022-168776

Published: 2022

Journal Articles

Efficient Knock-out of Serine Protease Cathepsin G Enhances Chemosensitivity to Cytarabine By Modulating the Cytarabine Metabolic Pathway Genes in Acute Myeloid Leukemia

Saswati Das, Raveen Stephen Stallon Illangeswaran, Daniel Zechariah Paul Jebanesan, Esther Sathya Bama Benjamin, Rakhi Thalayatta Vidhyadharan, Vikram Mathews, Shaji Ramachandran Velayudhan, Poonkuzhali Balasubramanian

Blood (2022) 140 (Supplement 1): 11542.

https://doi.org/10.1182/blood-2022-168817

Published: 2022

Journal Articles

Rxra Overexpression Improves the Sensitivity to Imatinib I n-Vitro/in-Vivo By Disrupting the Oxidative Capacity of Chronic Myeloid Leukemia Cells

Raveen Stephen Stallon Illangeswaran, Bharathi M Rajamani, Esther Sathya Bama Benjamin, Saswati Das, Daniel Zechariah Paul Jebanesan, Vikram Mathews, Shaji Ramachandran Velayudhan, Poonkuzhali Balasubramanian

Blood (2022) 140 (Supplement 1): 9595–9596.

https://doi.org/10.1182/blood-2022-168634

Published: 2022

Journal Articles

Genetic Ablation of Nuclear Receptor Interacting Protein 1 (NRIP1) Sensitizes Acute Myeloid Leukemia Cells to Retinoic Acids

Raveen Stephen Stallon Illangeswaran, Sreeja Karathedath, Abhirup Bagchi, Bharathi M Rajamani, Balaji Balakrishnan, Vikram Mathews, Shaji Ramachandran Velayudhan, Poonkuzhali Balasubramanian

Blood (2021) 138 (Supplement 1): 1146.

https://doi.org/10.1182/blood-2021-152058

Published: 2021

Journal Articles

Treosulfan Metabolite (S, S-EBDM) Pharmacokinetics Influences Regimen Related Toxicity in Patients with Beta Thalassaemia Major Undergoing HSCT

Aswin Anand PAI, MSc, John C Panetta, PhD, Ezhil Pavai Mohanan, PhD, Raveen Stephen Stallon Illangeswaran, MSc, Balaji Balakrishnan, PhD, Eunice Sindhuvi Edison, PhD, Kavitha M Lakshmi, MSc, Uday Prakash Kulkarni, MD DM, Anup Joseph Devasia, MD DM, Fouzia N., Anu Korula, MD DM, Aby Abraham, MD DM, Biju George, MDDM, Vikram Mathews, MD DM, Alok Srivastava, MD,FRACP,FRCPA, Poonkuzhali Balasubramanian, PhD

Blood (2019) 134 (Supplement_1): 1977.

https://doi.org/10.1182/blood-2019-125604

Published: 2019

Journal Articles

Global Gene Expression Analysis Reveals Genotoxic Effect of Nrf2 Pharmacological Inhibitor Brusatol in Myeloid Leukemia Cells- a Promising Novel Anticancer Agent

Raveen Stephen Stallon Illangeswaran, MSc, Sreeja Karathedath, PhD, Bharathi M Rajamani, Poonkuzhali Balasubramanian, MSc

Blood (2018) 132 (Supplement 1): 5150.

https://doi.org/10.1182/blood-2018-99-117829

Published: 2018

Journal Articles

Molecular and Pharmacological Inhibition of ATP Binding Cassette Transporter ABCB6 Decreases Chemoresistance in Acute Myeloid Leukemia

Sreeja Karathedath, PhD, Raveen Stephen Stallon Illangeswaran, M.Sc.,, Saswati Das, MSc., Bharathi M Rajamani, Srujan Kumar Marepally, M.Sc., PhD, Partha Kasturi, PhD, Vikram Mathews, MD DM, Shaji Ramachandran Velayudhan, M.Sc., PhD, Poonkuzhali Balasubramanian, MSc, PhD

Blood (2017) 130 (Supplement 1): 1254.

https://doi.org/10.1182/blood.V130.Suppl_1.1254.1254

Published: 2017

Journal Articles

Pharmacokinetics of Treosulfan in Patients with Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation — a Comparison of Two Formulations and Correlation with Clinical Outcomes

Alok Srivastava, MD, Ezhilpavai Mohanan, Msc, Raveen Stephen Stallon Illangeswaran, M.Sc.,, Carl Panetta, PhD, Kavitha M Lakshmi, MSc, Anu Korula, MD DM, Aby Abraham, MD DM, Biju George, MDDM, Vikram Mathews, MD DM, Poonkuzhali Balasubramanian, MSc, PhD

Blood (2017) 130 (Supplement 1): 3219.

https://doi.org/10.1182/blood.V130.Suppl_1.3219.3219

Published: 2017

NARROW

Targeting Cholesterol Homeostasis Pathway to Overcome Acquired Cytarabine Resistance in Acute Myeloid Leukemia

Efficient Knock-out of Serine Protease Cathepsin G Enhances Chemosensitivity to Cytarabine By Modulating the Cytarabine Metabolic Pathway Genes in Acute Myeloid Leukemia

Rxra Overexpression Improves the Sensitivity to Imatinib I n-Vitro/in-Vivo By Disrupting the Oxidative Capacity of Chronic Myeloid Leukemia Cells

Genetic Ablation of Nuclear Receptor Interacting Protein 1 (NRIP1) Sensitizes Acute Myeloid Leukemia Cells to Retinoic Acids

Treosulfan Metabolite (S, S-EBDM) Pharmacokinetics Influences Regimen Related Toxicity in Patients with Beta Thalassaemia Major Undergoing HSCT

Global Gene Expression Analysis Reveals Genotoxic Effect of Nrf2 Pharmacological Inhibitor Brusatol in Myeloid Leukemia Cells- a Promising Novel Anticancer Agent

Molecular and Pharmacological Inhibition of ATP Binding Cassette Transporter ABCB6 Decreases Chemoresistance in Acute Myeloid Leukemia

Pharmacokinetics of Treosulfan in Patients with Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation — a Comparison of Two Formulations and Correlation with Clinical Outcomes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only